Differences in refractory-period response of canine subendocardium and subepicardium to bunazosin, an alpha1-adrenoceptor antagonist, and propranolol during myocardial ischemia

Journal of Cardiovascular Pharmacology
T TanabeS Handa

Abstract

Our objective was to investigate the effects of alpha1- or beta-adrenoceptor blockers on endocardial and epicardial refractory-period changes during myocardial ischemia in alpha-chloralose-anesthetized dogs. The first and second diagonal branches of the left anterior descending coronary artery were ligated. The refractory period was determined by an S1-S2 extrastimulus method. Dogs were treated with the alpha1-blocker bunazosin (0.1-0.2 mg/kg, i.v.; n = 16), the beta-blocker propranolol (0.2 mg/kg, i.v.; n = 15), or saline (n = 11). Dogs that developed ventricular tachycardia/fibrillation (VT/VF) during the experiment were excluded from the statistical assessment in refractory periods. In all groups, coronary ligation produced a significant shortening of the refractory period of ischemic epicardial tissue (p < 0.05) but only minimal shortening of ischemic endocardial refractory periods, resulting in an increased difference in repolarization time between the endo- and epicardial sites. Treatment with bunazosin ameliorated this ischemia-related shortening of refractory periods at both the endo- and epicardial sites, with a greater effect seen epicardially (p < 0.05), resulting in values similar to those in the nonischemic tissue....Continue Reading

References

Jan 1, 1990·Circulation·G Heusch
Jan 1, 1988·Circulation Research·S H Litovsky, C Antzelevitch
Aug 7, 1986·European Journal of Pharmacology·D J WilberB R Lucchesi
Jul 1, 1971·Circulation·T N James, L Sherf
Apr 1, 1969·Cardiovascular Research·L CeremuzyńskiK Herbaczynska-Cedro
Oct 1, 1965·The American Journal of Physiology·A DahlströmB E Zetterström
Feb 1, 1982·Japanese Journal of Pharmacology·F HataH Ishida
Jan 1, 1980·The Journal of Clinical Investigation·D J SheridanP B Corr
Jun 1, 1994·Cardiovascular Research·A A WildeT Opthof
Aug 1, 1993·Cardiovascular Drugs and Therapy·A A Wilde

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.